Source: BioSpace

Amerigen: Amerigen to Commercialize Two of Inventia's ANDA's

Amerigen Pharmaceuticals Limited and Inventia Healthcare Limited announced they had entered into a collaboration involving two of Inventia's recently approved U.S. ANDA's.

Read full article »
Amerigen's Competitors | Amerigen's News | Amerigen's Financials
Stay up-to-date with the latest news on Amerigen
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
John W. Lowry's photo - President & CEO of Amerigen

President & CEO

John W. Lowry

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Amerigen